Advertisement

Topics

FDA Cites Lupin For Poor Quality Metric Performance

11:03 EDT 30 Jun 2017 | SCRIP

Indian firm's invalidated out-of-specification rate was too high, FDA suggests in heavily redacted Form 483 report. This rate, which also...

      

Related Stories

 

Original Article: FDA Cites Lupin For Poor Quality Metric Performance

NEXT ARTICLE

More From BioPortfolio on "FDA Cites Lupin For Poor Quality Metric Performance"

Advertisement
Quick Search
Advertisement
Advertisement